Literature DB >> 29467856

Smoking and female sex as key risk factors associated with severe arthralgia in acute and chronic phases of Chikungunya virus infection.

Ivan Delgado-Enciso1,2, Brenda Paz-Michel3, Valery Melnikov1, Jose Guzman-Esquivel4, Francisco Espinoza-Gomez1, Alejandro D Soriano-Hernandez1,2, Iram P Rodriguez-Sanchez5, Margarita L Martinez-Fierro6, Gabriel Ceja-Espiritu1,4, Bertha A Olmedo-Buenrostro1, Hector R Galvan-Salazar2,6, Osiris G Delgado-Enciso7, Josuel Delgado-Enciso7, Uriel A Lopez-Lemus8, Daniel A Montes-Galindo2.   

Abstract

Arthralgia is a potentially incapacitating condition and a persistent symptom in chronic or acute episodes of Chikungunya fever caused by infection with the Chikungunya virus (CHIKV). To the best of our knowledge, there are no reports on risk factors associated with the intensity of arthralgias in typical acute episodes of the disease. Although a number of studies have reported on risk factors associated with the development of the chronic stage of the disease, smoking habits have not been analyzed. Smoking is an interesting factor to consider since it is the main environmental risk factor for the development of rheumatoid arthritis (RA), a similar disease to CHIKV in many aspects. In the present study, 140 patients infected with CHIKV were assessed for risk factors associated with severe arthralgia intensity in the acute phase (pain of 9/10 on the visual analog scale of 0-10) and moderate to severe intensity (according to the Routine Assessment of Patient Index Data 3) 3.5 months after infection in patients that experienced the chronic phase of the disease. Women and smokers were 2- to 3-times more likely to experience severe pain in the acute and chronic stages. Likewise, the presence of severe arthralgia during the acute disease phase resulted in a 4-fold increased risk for entering the chronic phase. Smoking was a more important risk factor in males compared with females. Smoking resulted in a 20-fold increased risk for severe arthralgia during the acute phase in men, as well as a 10-fold increased risk for developing chronic disease with moderate-to-severe pain 3.5 months after the acute stage. The presence of rash, headache, muscular weakness or conjunctivitis in the acute phase, the presence of diabetes and age >40 years were considered significant risk factors due to their influence on illness progression. In conclusion, smoking and female sex were the main risk factors associated with development of severe joint pain in the acute and chronic phases of Chikungunya fever. These risk factors are similar to those associated with the development and severity of RA, possibly because the two diseases share pathophysiological mechanisms, including elevated interleukin-6 levels.

Entities:  

Keywords:  Chikungunya virus; arthralgia; interleukin-6; rheumatoid arthritis; risk factor

Year:  2017        PMID: 29467856      PMCID: PMC5792796          DOI: 10.3892/etm.2017.5668

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  44 in total

1.  Asking the community about cutpoints used to describe mild, moderate, and severe pain.

Authors:  Guadalupe R Palos; Tito R Mendoza; Gary M Mobley; Scott B Cantor; Charles S Cleeland
Journal:  J Pain       Date:  2006-01       Impact factor: 5.820

2.  Impaired NK cell functionality and increased TNF-α production as biomarkers of chronic chikungunya arthritis and rheumatoid arthritis.

Authors:  Subrat Thanapati; Mohini Ganu; Prashant Giri; Shruti Kulkarni; Meenal Sharma; Prasad Babar; Ashok Ganu; Anuradha S Tripathy
Journal:  Hum Immunol       Date:  2017-02-14       Impact factor: 2.850

Review 3.  The role and therapeutic targeting of IL-6 in rheumatoid arthritis.

Authors:  Masashi Narazaki; Toshio Tanaka; Tadamitsu Kishimoto
Journal:  Expert Rev Clin Immunol       Date:  2017-03-03       Impact factor: 4.473

4.  Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort.

Authors:  Athan Baillet; Laure Gossec; Simon Paternotte; Adrien Etcheto; Bernard Combe; Olivier Meyer; Xavier Mariette; Jacques-Eric Gottenberg; Maxime Dougados
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-07       Impact factor: 4.794

Review 5.  Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies.

Authors:  D Sugiyama; K Nishimura; K Tamaki; G Tsuji; T Nakazawa; A Morinobu; S Kumagai
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

6.  Impaired lung homeostasis in neonatal mice exposed to cigarette smoke.

Authors:  Sharon McGrath-Morrow; Tirumalai Rangasamy; Cecilia Cho; Thomas Sussan; Enid Neptune; Robert Wise; Rubin M Tuder; Shyam Biswal
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11-01       Impact factor: 6.914

7.  Persistently active disease is common in patients with rheumatoid arthritis, particularly in women: a long-term inception cohort study.

Authors:  B Svensson; Mle Andersson; K Forslind; S Ajeganova; I Hafström
Journal:  Scand J Rheumatol       Date:  2016-04-20       Impact factor: 3.641

8.  Determining mild, moderate, and severe pain equivalency across pain-intensity tools in nursing home residents.

Authors:  Katherine R Jones; Carol P Vojir; Evelyn Hutt; Regina Fink
Journal:  J Rehabil Res Dev       Date:  2007

9.  Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis.

Authors:  Jonathan J Miner; Han-Xian Aw-Yeang; Julie M Fox; Samantha Taffner; Olga N Malkova; Stephen T Oh; Alfred H J Kim; Michael S Diamond; Deborah J Lenschow; Wayne M Yokoyama
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

10.  Retrospective review of epidemic viral pneumonia cases in Turkey: A multicenter study.

Authors:  Mustafa Çörtük; Murat Acat; Onur Yazici; Zehra Yasar; Kemal Kiraz; Sena Yapicioglu Ataman; Elif Tanriverdi; Burcak Zitouni; Cenk Kirakli; Ozlem Ediboglu; Fevziye Tuksavul; Adem Dirican; Hale Kefeli Celik; Sevket Ozkaya; Erdogan Cetinkaya
Journal:  Exp Ther Med       Date:  2017-02-22       Impact factor: 2.447

View more
  8 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  Systemic Administration of Neutral Electrolyzed Saline as a Novel Treatment for Rheumatoid Arthritis Reduces Mechanical and Inflammatory Damage to the Joints: Preclinical Evaluation in Mice.

Authors:  Sergio A Zaizar-Fregoso; Brenda A Paz-Michel; Alejandrina Rodriguez-Hernandez; Juan Paz-Garcia; Nomely S Aurelien-Cabezas; Daniel Tiburcio-Jimenez; Valery Melnikov; Efren Murillo-Zamora; Osiris G Delgado-Enciso; Ariana Cabrera-Licona; José Guzman-Esquivel; Carlos E Barajas-Saucedo; Iram P Rodriguez-Sanchez; Margarita L Martinez-Fierro; Norma A Moy-López; Agustin Lara-Esqueda; Jorge Guzman-Muñiz; Marina Delgado-Machuca; Ivan Delgado-Enciso
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-02       Impact factor: 2.650

Review 3.  Risk Factors and Prevention Strategies for Postoperative Opioid Abuse.

Authors:  Shuai Zhao; Fan Chen; Anqi Feng; Wei Han; Yuan Zhang
Journal:  Pain Res Manag       Date:  2019-07-10       Impact factor: 3.037

4.  Risks Related to Chikungunya Infections among European Union Travelers, 2012-2018.

Authors:  Céline M Gossner; Nelly Fournet; Joana Gomes Dias; Beatriz Fernández Martínez; Martina Del Manso; Johanna J Young; Hervé Zeller; Denis Coulombier
Journal:  Emerg Infect Dis       Date:  2020-06       Impact factor: 6.883

5.  Acute-Phase Levels of CXCL8 as Risk Factor for Chronic Arthralgia Following Chikungunya Virus Infection.

Authors:  Leile Camila Jacob-Nascimento; Caroline Xavier Carvalho; Monaíse Madalena Oliveira Silva; Mariana Kikuti; Rosângela Oliveira Anjos; Jordana Rodrigues Barbosa Fradico; Ana Carolina Campi-Azevedo; Laura Beatriz Tauro; Gúbio Soares Campos; Patricia Sousa Dos Santos Moreira; Moyra Machado Portilho; Olindo Assis Martins-Filho; Guilherme Sousa Ribeiro; Mitermayer Galvão Reis
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

6.  Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial.

Authors:  Ivan Delgado-Enciso; Juan Paz-Garcia; Carlos E Barajas-Saucedo; Karen A Mokay-Ramírez; Carmen Meza-Robles; Rodrigo Lopez-Flores; Marina Delgado-Machuca; Efren Murillo-Zamora; Jose A Toscano-Velazquez; Josuel Delgado-Enciso; Valery Melnikov; Mireya Walle-Guillen; Hector R Galvan-Salazar; Osiris G Delgado-Enciso; Ariana Cabrera-Licona; Eduardo J Danielewicz-Mata; Pablo J Mandujano-Diaz; José Guzman-Esquivel; Daniel A Montes-Galindo; Henry Perez-Martinez; Jesus M Jimenez-Villegaz; Alejandra E Hernandez-Rangel; Patricia Montes-Diaz; Iram P Rodriguez-Sanchez; Margarita L Martinez-Fierro; Idalia Garza-Veloz; Daniel Tiburcio-Jimenez; Sergio A Zaizar-Fregoso; Fidadelfo Gonzalez-Alcaraz; Laydi Gutierrez-Gutierrez; Luciano Diaz-Lopez; Mario Ramirez-Flores; Hannah P Guzman-Solorzano; Gustavo Gaytan-Sandoval; Carlos R Martinez-Perez; Francisco Espinoza-Gómez; Fabián Rojas-Larios; Michael J Hirsch-Meillon; Luz M Baltazar-Rodriguez; Enrique Barrios-Navarro; Vladimir Oviedo-Rodriguez; Martha A Mendoza-Hernandez; Emilio Prieto-Diaz-Chavez; Brenda A Paz-Michel
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

7.  Imported Arbovirus Infections in Spain, 2009-2018.

Authors:  Francesca F Norman; César Henríquez-Camacho; Marta Díaz-Menendez; Sandra Chamorro; Diana Pou; Israel Molina; Josune Goikoetxea; Azucena Rodríguez-Guardado; Eva Calabuig; Clara Crespillo; Inés Oliveira; José-Antonio Pérez-Molina; Rogelio López-Velez
Journal:  Emerg Infect Dis       Date:  2020-04       Impact factor: 6.883

8.  Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled Trial.

Authors:  Ivan Delgado-Enciso; Juan Paz-Garcia; Carlos E Barajas-Saucedo; Karen A Mokay-Ramírez; Carmen Meza-Robles; Rodrigo Lopez-Flores; Marina Delgado-Machuca; Efren Murillo-Zamora; Jose A Toscano-Velazquez; Josuel Delgado-Enciso; Valery Melnikov; Mireya Walle-Guillen; Hector R Galvan-Salazar; Osiris G Delgado-Enciso; Ariana Cabrera-Licona; José Guzman-Esqu; Daniel A Montes-Galindo; Alejandra E Hernandez-Rangel; Patricia Montes-Diaz; Iram P Rodriguez-Sanchez; Margarita L Martinez-Fierro; Idalia Garza-Veloz; Daniel Tiburcio-Jimenez; Sergio A Zaizar-Fregoso; Mario Ramirez-Flores; Gustavo Gaytan-Sandoval; Carlos R Martinez-Perez; Francisco Espinoza-Gómez; Fabián Rojas-Larios; Michael J Hirsch-Meillon; Enrique Barrios-Navarro; Vladimir Oviedo-Rodriguez; Luz M Baltazar Rodriguez; Brenda A Paz-Michel
Journal:  Res Sq       Date:  2020-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.